CATTLEVAX

Страна: Нова Зеландия

Език: английски

Източник: Ministry for Primary Industries

Активна съставка:

clostridium perfringens type d toxoid; clostridium tetani toxoid; clostridium novyi type b toxoid/cells; clostridium septicum toxoid; leptospira interrogans serovar pomona; leptospira borgpetersenii serovar hardjo; clostridium chauvoei toxoid/cells

Предлага се от:

Schering-Plough Animal Health Limited

INN (Международно Name):

clostridium septicum toxoid, clostridium novyi type b toxoid/cells, clostridium perfringens type d toxoid, leptospira interrogan

Композиция:

clostridium perfringens type d toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium septicum toxoid 0 vaccine; leptospira interrogans serovar pomona 0 vaccine; leptospira borgpetersenii serovar hardjo 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine

Терапевтична област:

Vaccine

Статус Оторизация:

ACVM Registered

Дата Оторизация:

1992-10-02

Данни за продукта

CATTLEVAX
Carton and Label
A006499
Page 1 of 3
CATTLEVAX
07-Oct-2020
Carton
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF THE REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
CATTLEVAX
®
COMBINED LEPTO AND 5 IN 1 FOR BEEF, DAIRY CATTLE AND CALVES
CONTAINS PURIFIED TOXOIDS OF _CLOSTRIDIUM_ _PERFRINGENS_ TYPE D, _C.
TETANI_, _C. SEPTICUM_ AND _C._
_NOVYI _AND INACTIVATED _C. CHAUVOEI_ AND _LEPTOSPIRA INTERROGANS_
SEROTYPES POMONA AND
HARDJO ANTIGENS.
READ ENTIRE CARTON BEFORE USE.
USES
For the active immunisation of cattle against the five major
clostridial diseases:
Enterotoxaemia (Pulpy Kidney)
Tetanus
Malignant Oedema
Black Disease (Necrotic Hepatitis)
Blackleg
and against Leptospirosis caused by _L. hardjo_ and _L. pomona_.
The vaccination of healthy cattle before infection will prevent the
urinary shedding of leptospirae
thereby preventing the transmission of the disease to humans and other
cattle. Vaccination will
not alter the shedding status of already infected animals.
VACCINATION
PROGRAMME
PRIMARY VACCINATION
Two 4 mL doses administered at least four weeks apart and preferably 4
to 6 weeks apart.
Optimum protection is attained two weeks after the administration of
the second dose. The
vaccination course should therefore be completed 2 weeks prior to the
period of risk.
Maternal antibodies may interfere with the response to vaccination if
administered before 6
months of age.
Calves exposed to a high risk may be vaccinated from 4 weeks of age.
However, it is essential
that a booster dose is administered once they reach six months of age.
All animals introduced to the dairy herd must either have a reliably
documented and effective
Leptospirosis vaccination history or to be treated with streptomycin
at recommended dose rates
for leptospirosis and receive a full primary vaccination.
BOOSTER VACCINATION
An annual single 4mL dose is required. However in those areas where
clostridial disease
challenge (especially Black Disease) is particularly high, six monthly
booster doses should be
administered.
DOSAGE
AND
ADMINISTRA